Empowering biopharma with enhanced safety insights to anticipate
risks and unlock new competitive advantages
LONDON, July 30,
2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a
leading global provider of transformative intelligence, today
announced the launch of the new OFF-X™ platform. The enhanced
solution offers a seamless user experience and unique translational
insights. It delivers crucial drug and target safety intelligence
to proactively identify risks. Fully integrated with Cortellis Drug
Discovery Intelligence™, OFF-X™ provides a comprehensive, one-stop
resource for safety information, streamlining processes and
enhancing efficiency which ultimately delivers a competitive
edge.
The new platform features an upgraded technology stack and
enhanced functionality while retaining its core capabilities. These
improvements include an 80% reduction in loading times for targets,
drugs, drug combinations and adverse events. The platform now
offers faster search capabilities, a clearer visual design,
full-screen visualization and additional analytic tools.
Justin Hubbard, Vice
President, Product Management, Life Sciences and Healthcare at
Clarivate, said: "The launch of the new OFF-X™
platform underscores our dedication to providing actionable,
comprehensive solutions in life sciences and healthcare. OFF-X
revolutionizes access to safety information across all drug R&D
and post-marketing phases, with speed and customization. By
combining our safety intelligence with advanced analytics, we
empower clients to accelerate the delivery of safe, effective and
commercially successful treatments to patients."
OFF-X empowers users to monitor and anticipate toxicology and
safety signals, mitigate safety liabilities and de-risk assets
across all phases of drug R&D and post-marketing, bolstering
confident development and investment decisions.
Learn more about OFF-X here.
About OFF-X™
OFF-X is the new translational safety intelligence platform that
facilitates integrated preclinical toxicity data, clinical and
pharmacovigilance adverse event data, visualizations and
preclinical safety analytics. Updated daily, the platform
incorporates wide-ranging analytics and visualizations, as well as
comprehensive range of safety information sources and datasets,
including a range of over 15,000 targets and more than 39,000 drugs
& biologics, populated with almost 3 million expertly curated
safety alerts associated to 14,000 adverse events and toxicity
endpoints.
About Clarivate
Clarivate™ is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
Media Contact:
Luna
Ivkovic,
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clarivate-introduces-new-off-x--platform-for-preclinical-and-clinical-safety-intelligence-302207891.html
SOURCE Clarivate Plc